Q4 2024 Results Conference Call March 19, 2025 8:30 AM ETCompany ParticipantsDan Ferry - IR, LifeSci AdvisorsOfer Gonen - ...

Typical lesions progress from red or gray macules or papules, to red or gray macules or papules with a central eschar or ulceration ... was easily removed with debridement scissors (see Figure ...

There may also be a dark substance in the open sore called eschar, which is hardened tissue that has died ... the affected area Removing any damaged tissue from the area (during a debridement) During ...

MediWound Ltd (NASDAQ: MDWD) reported its fourth-quarter 2024 earnings, showcasing a better-than-expected performance with an EPS of -0.36, surpassing the forecasted -0.56. Revenue for the quarter ...

Initiated VALUE, a global Phase III pivotal trial of EscharEx® for venous leg ulcers Expanded strategic research collaborations with industry leaders, now including Kerecis $20 million in revenue for ...